Article
Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.
Arthritis & rheumatology (Hoboken, N.J.) - 1 Jun 2016
Julià Antonio, Blanco Francisco, Fernández-Gutierrez Benjamín, González Antonio, Cañete Juan D, Maymó Joan, Alperi-López Mercedes, Olivè Alex, Corominas Héctor, Martínez-Taboada Víctor, González-Álvaro Isidoro, Fernandez-Nebro Antonio, Erra Alba, Sánchez-Fernández Simón, Alonso Arnald, López-Lasanta María, Tortosa Raül, Codó Laia, Lluis Gelpi Josep, García-Montero Andrés C, Bertranpetit Jaume, Absher Devin, Myers Richard M, Tornero Jesús, Marsal Sara
Abstract excerpt
OBJECTIVE: Rheumatoid factor (RF) is a well-established diagnostic and prognostic biomarker in rheumatoid arthritis (RA). However, ∼20% of RA patients are negative for this anti-IgG antibody. To date, only variation at the HLA-DRB1 gene has been associated with the presence of RF. This study was undertaken to identify additional genetic variants associated with RF positivity. METHODS: A genome-wide association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
